KOSDAQ · Healthcare · ₩178B
₩6,600+3.94%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 8.0% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“신사업 매출이 기반을 만들고 신약 기대를 키워가요.”
In the company's words · 2026 2분기 filing